Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Paulsen, J. E.
Right arrow Articles by Alexander, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulsen, J. E.
Right arrow Articles by Alexander, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 7, 1277-1282, July 1999
© 1999 Oxford University Press


Carcinogenesis

Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice

Jan Erik Paulsen*, Inger-Lise Steffensen*, Åshild Andreassen, Rose Vikse and Jan Alexander1

Department of Environmental Medicine, National Institute of Public Health, PO Box 4404 Torshov, N-0403 Oslo, Norway

We examined whether the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) could increase intestinal tumorigenesis in neonatal C57BL/6J-Min/+ mice, a murine model for familial adenomatous polyposis. Min/+ mice are heterozygous for a nonsense mutation in the adenomatous polyposis coli gene and spontaneously develop multiple intestinal adenomas, primarily in the small intestine. Neonatal Min/+ mice (3–6 days old) were exposed to PhIP via breast milk from lactating dams given 8 s.c. injections of 50 mg/kg PhIP three times a week or to 8 s.c. injections of 25 or 50 mg/kg PhIP directly, over the same period. At the age of 11 weeks, the number, diameter and location of the intestinal tumors were scored. Remarkably, a 2- to 4-fold increase in the number of small intestinal tumors was seen in Min/+ mice exposed to PhIP via breast milk (P < 0.001). To our knowledge, this is the first time PhIP has been reported to induce tumors following exposure via breast milk from PhIP-exposed dams. Upon direct exposure to 50 mg/kg PhIP, a 6- to 9-fold increase in the number of small intestinal tumors was observed (P < 0.001). The diameter of the PhIP-induced small intestinal tumors was slightly increased (P < 0.001). In the colon, a 3- to 4-fold increase in the number of tumors was seen in Min/+ mice exposed to PhIP via breast milk (P = 0.004). Direct exposure to 50 mg/kg PhIP caused a 2- to 6-fold increase in the number of colonic tumors (P = 0.014). The PhIP-induced colonic tumors were located more distally and displayed a smaller diameter than the tumors from the controls (P < 0.05). In contrast to a previous study, where PhIP showed only a moderate tumorigenic effect in adult Min/+ mice, the present study demonstrates a strong tumorigenic effect of PhIP in neonatally exposed Min/+ mice, even after exposure via breast milk from PhIP-exposed dams.

Abbreviations: ACF, aberrant crypt foci; APC/Apc, adenomatous polyposis coli gene (human/murine); FAP, familial adenomatous polyposis; Min, multiple intestinal neoplasia; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

1 To whom correspondence should be addressed Email: jan.alexander{at}folkehelsa.no

* These authors have contributed equally to this work


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
A K Lawrance, L Deng, and R Rozen
Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apcmin/+ mice
Gut, June 1, 2009; 58(6): 805 - 811.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
C. SVENDSEN, T. HUSOY, H. GLATT, J. E. PAULSEN, and J. ALEXANDER
5-Hydroxymethylfurfural and 5-Sulfooxymethylfurfural Increase Adenoma and Flat ACF Number in the Intestine of Min/+ Mice
Anticancer Res, June 1, 2009; 29(6): 1921 - 1926.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. E.v. Herwaarden, E. Wagenaar, B. Karnekamp, G. Merino, J. W. Jonker, and A. H. Schinkel
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk
Carcinogenesis, January 1, 2006; 27(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. W. Greiner, H. Zeytin, M. R. Anver, and J. Schlom
Vaccine-based Therapy Directed against Carcinoembryonic Antigen Demonstrates Antitumor Activity on Spontaneous Intestinal Tumors in the Absence of Autoimmunity
Cancer Res., December 1, 2002; 62(23): 6944 - 6951.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I.-L. Steffensen, J. E. Paulsen, and J. Alexander
The food mutagen 2-amino-9H-pyrido[2,3-b]indole (A{alpha}C) but not its methylated form (MeA{alpha}C) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice
Carcinogenesis, August 1, 2002; 23(8): 1373 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander
Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts
Cancer Res., December 1, 2001; 61(24): 8689 - 8696.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander
Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele
Mutagenesis, July 1, 2001; 16(4): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Erik Paulsen, I.-L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander
Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon
Cancer Res., July 1, 2001; 61(13): 5010 - 5015.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. P. Collett, C. N. Robson, J. C. Mathers, and F. C. Campbell
Curcumin modifies Apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apcmin mice
Carcinogenesis, May 1, 2001; 22(5): 821 - 825.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. S. Kulp, M. G. Knize, M. A. Malfatti, C. P. Salmon, and J. S. Felton
Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans
Carcinogenesis, November 1, 2000; 21(11): 2065 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Song, A. Medline, J. B. Mason, S. Gallinger, and Y.-I. Kim
Effects of Dietary Folate on Intestinal Tumorigenesis in the ApcMin Mouse
Cancer Res., October 1, 2000; 60(19): 5434 - 5440.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
K. M. Gressani, S. Leone-Kabler, M. G. O'Sullivan, A. J. Townsend, and M. S. Miller
Prenatal Toxicity and Lack of Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) following Transplacental Exposure
Toxicol. Sci., June 1, 2000; 55(2): 407 - 414.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.